Advertisement
Advertisement
TGTX
TG Therapeutics, Inc.
55.27
USDSponsored
-0.10
-0.18%
Oct 12, 15:59 UTC -4
Closed
After-Market
55.26
-0.01
-0.02%
TG Therapeutics, Inc. Financial Snapshot
| Market Cap | 8.46B |
| Beta | 1.80 |
| Earnings Per Share (EPS) | 2.74 |
| Price-to-Book (P/B) Ratio | 14.03 |
| Operating Margin | 56.12% |
| Total Debt/Equity (D/E) | 123.39% |
| P/E Ratio | 19.85 |
| Return on Equity (ROE) | 73.49% |
| Current Ratio | 4.27% |
| Free Cash Flow | 21.02M |
